Batista, LF; Roos, WP; Kaina, B et al.
p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removalMol Cancer Res. Bd. 7. H. 2. 2009 S. 237-46
Stebel, A; Brachetti, C; Kunkel, M et al.
Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1ONCOLOGY REPORTS. Bd. 21. H. 1. 2009 S. 217-222
Oesch-Bartlomowicz, B; Oesch, F
Role of cAMP in mediating AHR signalingBiochem Pharmacol. Bd. 77. H. 4. 2009 S. 627-41
Fritz, G; Issinger, OG; Olsen, BB
Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responsesINTERNATIONAL JOURNAL OF ONCOLOGY. Bd. 35. H. 5. 2009 S. 1151-1157
Fritz, G
Targeting the mevalonate pathway for improved anticancer therapy.Curr Cancer Drug Targets. Bd. 9. H. 5. 2009 S. 626-38
Naumann, SC; Roos, WP; Jost, E et al.
Temozolomide cells: response related to MGMT, MMR, DSBs, and p53Br J Cancer. Bd. 100. H. 2. 2009 S. 322-33
Roos, WP; Tsaalbi-Shtylik, A; Tsaryk, R et al.
The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugsMol Pharmacol. Bd. 76. H. 4. 2009 S. 927-34
Brozovic, A; Majhen, D; Roje, V et al.
alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative speciesMol Pharmacol. Bd. 74. H. 1. 2008 S. 298-306
Goldstein, M; Roos, WP; Kaina, B
Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.Toxicol Appl Pharmacol. Bd. 229. H. 1. 2008 S. 20-32